Biopharma Vital Signs – Part 4: The New Partnership Playbook - Top-Institutions - MDSpire

Biopharma Vital Signs – Part 4: The New Partnership Playbook

Experts discuss how biopharma partnerships are evolving, as companies look beyond transactional supplier relationships toward more integrated, strategic, and collaborative models

  • July 10, 2026

  • 15 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mass General Brigham
    Mass General Brigham

    Boston, Massachusetts

    Key Differentiators

    • Cancer
    • Cardiovascular Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Comprehensive Cancer Care

  • #3

    Baxter
    Baxter

    Deerfield, Illinois

    Key Differentiators

    • Hemophilia Treatment

  • #4

    Sylvester Comprehensive Cancer Center
    Sylvester Comprehensive Cancer Center

    Miami, Florida

    Key Differentiators

    • Hematologic Oncology

  • #5

    University of Miami Miller School of Medicine
    University of Miami Miller School of Medicine

    Miami, Florida

    Key Differentiators

    • Hematologic Oncology

Original Source(s)

Biopharma Vital Signs – Part 4: The New Partnership Playbook

  • July 10, 2026

Related Content

Huangjin Shuangshen decoction alleviates chronic atrophic gastritis by suppressing TNF/NF-κB signaling and promoting CFTR-associated gastric mucosal barrier repair

Diagnostic performance of a single breath-hold lung MRI scan with AI-powered compressed sensing for nodule detection in comparison to photon counting detector-CT

HPV-associated moderately differentiated squamous cell carcinoma of the cervix with pathologically confirmed bladder invasion and radiologically presumed adrenal metastasis in a patient with prior lung adenocarcinoma resection: a rare case report and clinical discussion